The Board


Mikko-Jussi Suonenlahti – Chairman of the Board, VTT Ventures representative

Senior advisor at DFJ Esprit. 30 years of operational (CEO, sales, R&D) and VC (investment and team management) experience in business building. Investor in 14 technology businesses in the US and Finland, which have raised $300M and are valued at $1 Billion. Venture partner at DFJ Esprit and board member of Estonia Development Fund’s SmartCap.

Kalle Åström – Board member, Investor representative (Finnvera Oyj)

Investment manager, 14 years of experience in international financial markets.

Prof. Olli Kallioniemi – Board member, Co-founder representative

Professor and Director of the Institute for Molecular Medicine Finland (FIMM) at the University of Helsinki. Expert in cancer genomics and individualized systems medicine and co-inventor of key technologies, such as FISH, CGH, tissue microarrays. Author of 319 publications and 20 patents. He has held several positions internationally, including the Head of Translational Genomics Section at the Cancer Genetics Branch, National Human Genome Research Institute, at NIH.

Prof. Jonathan Knowles – Board member, Industry expert

Former Head of Group Research and Member of the Executive Committee at Roche. He was a member of the Board at Genentech for the last 12 years as well as a member of the Chugai Pharmaceuticals Board. He was also the founding chairman of the Innovative Medicines Initiative Board. Prof. Knowles has made significant contribution to academic research in his various roles at University of Oxford, EPFL in Switzerland and most recently as Distinguished Professor in Personalized Healthcare at the Institute for Molecular Medicine Finland (FIMM)